Role of dendritic cells in enhancement of herpes simplex virus type 1 latency and reactivation in vaccinated mice

Clinical and Vaccine Immunology

Volumn 15, Issue 12, 2008, Pages 1859-1867

  Mott, Kevin R ^a   Ghiasi, Homayon ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; DNA VACCINE; GLYCOPROTEIN P 15095;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEPHARITIS; CONTROLLED STUDY; DENDRITIC CELL; EYE INFECTION; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; LATENT VIRUS INFECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC ORGANISM; TRIGEMINUS GANGLION; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION;

ANIMALS; DENDRITIC CELLS; DIPHTHERIA TOXIN; HERPES SIMPLEX; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 1, HUMAN; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; TRIGEMINAL GANGLION; VACCINES, DNA; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

EID: 57349131656     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00318-08     Document Type: Article

References (75)

1. Albers, I., H. Kirchner, and I. Domke-Opitz. 1989. Resistance of human blood monocytes to infection with herpes simplex virus. Virology 169:466-469.
2. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89.
3. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
4. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682-687.
5. Barron, B. A., L. Gee, W. W. Hauck, N. Kurinij, C. R. Dawson, D. B. Jones, K. R. Wilhelmus, H. E. Kaufman, J. Sugar, R. A. Hyndiuk, et al. 1994. Herpetic eye disease study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 101:1871-1882.
6. Bellone, M., G. Iezzi, P. Rovere, G. Galati, A. Ronchetti, M. P. Protti, J. Davoust, C. Rugarli, and A. A. Manfredi. 1997. Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. 159:5391-5399.
7. + dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J. Immunol. 175:196-200.
8. Bennett, C. L., and B. E. Clausen. 2007. DC ablation in mice: promises, pitfalls, and challenges. Trends Immunol. 28:519-525.
9. Blattman, J. N., and P. D. Greenberg. 2004. Cancer immunotherapy: a treatment for the masses. Science 305:200-205.
10. Brown, D. C., A. B. Nesburn, J. S. Nauheim, D. Pavan-Langston, and H. E. Kaufman. 1968. Recurrent herpes simplex conjunctivitis. Arch. Ophthalmol. 79:733-735.
11. Chen, M., Y. H. Wang, Y. Wang, L. Huang, H. Sandoval, Y. J. Liu, and J. Wang. 2006. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311:1160-1164.
12. Colonna, M., B. Pulendran, and A. Iwasaki. 2006. Dendritic cells at the host-pathogen interface. Nat. Immunol. 7:117-120.
13. Corey, L. 1994. The current trend in genital herpes. Progress in prevention. Sex. Transm. Dis. 21:S38-S44.
14. high murine dendritic cells in vivo: a comparative analysis with Flt3 ligand. J. Immunol. 165:49-58.
15. Dix, R. D. 2002. Pathogenesis of herpes simplex ocular disease, vol. 2. Lippincott, Williams and Wilkins, Philadelphia, PA.
16. Dix, R. D. 1987. Prospects for a vaccine against herpes simplex virus types 1 and 2. Prog. Med. Virol. 34:89-128.
17. Dobson, A. T., T. P. Margolis, F. Sedarati, J. G. Stevens, and L. T. Feldman. 1990. A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons. Neuron 5:353-360.
18. Engelmayer, J., M. Larsson, M. Subklewe, A. Chahroudi, W. I. Cox, R. M. Steinman, and N. Bhardwaj. 1999. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163:6762-6768.
19. Evel-Kabler, K., and S. Y. Chen. 2006. Inhibition of antigen-presentation attenuators to augment vaccines. Curr. Opin. Mol. Ther. 8:24-30.
20. Fiore, N., G. Castellano, A. Blasi, C. Capobianco, A. Loverre, V. Montinaro, S. Netti, D. Torres, C. Manno, G. Grandaliano, E. Ranieri, F. P. Schena, and L. Gesualdo. 2008. Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. Mol. Immunol. 45:259-265.
21. Fraser, N. W., T. M. Block, and J. G. Spivack. 1992. The latency-associated transcripts of herpes simplex virus: RNA in search of function. Virology 191:1-8.
22. Fujikado, N., S. Saijo, T. Yonezawa, K. Shimamori, A. Ishii, S. Sugai, H. Kotaki, K. Sudo, M. Nose, and Y. Iwakura. 2008. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat. Med. 14:176-180.
23. Geijtenbeek, T. B., D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. KewalRamani, D. R. Littman, C. G. Figdor, and Y. van Kooyk. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587-597.
24. Ghiasi, H., S. Bahri, A. B. Nesburn, and S. L. Wechsler. 1995. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Investig. Ophthalmol. Vis. Sci. 36:1352-1360.
25. Ghiasi, H., S. Cai, A. B. Nesburn, and S. L. Wechsler. 1997. MHC-II but not MHC-I responses are required for vaccine-induced protection against ocular challenge with HSV-1. Curr. Eye Res. 16:1152-1158.
26. Ghiasi, H., S. Cai, G. C. Perng, A. B. Nesburn, and S. L. Wechsler. 2000. The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection. Antivir. Res. 45:33-45.
27. Ghiasi, H., R. Kaiwar, A. B. Nesburn, S. Slanina, and S. L. Wechsler. 1994. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J. Virol. 68:2118-2126.
28. Ghiasi, H., S. L. Wechsler, S. Cai, A. B. Nesburn, and F. M. Hofman. 1998. The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge. Immunology 95:352-359.
29. Ghiasi, H., S. L. Wechsler, R. Kaiwar, A. B. Nesburn, and F. M. Hofman. 1995. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1. J. Virol. 69:334-340.
30. Grabbe, S., E. Kampgen, and G. Schuler. 2000. Dendritic cells: multi-lineal and multi-functional. Immunol. Today 21:431-433.
31. Granelli-Piperno, A., E. Delgado, V. Finkel, W. Paxton, and R. M. Steinman. 1998. Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J. Virol. 72:2733-2737.
32. Hill, J. M., B. M. Gebhardt, R. Wen, A. M. Bouterie, H. W. Thompson, R. J. O'Callaghan, W. P. Halford, and H. E. Kaufman. 1996. Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency. J. Virol. 70:3137-3141.
33. Hill, J. M., F. Sedarati, R. T. Javier, E. K. Wagner, and J. G. Stevens. 1990. Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology 174:117-125.
34. Hobbs, M. R., B. B. Jones, B. E. Otterud, M. Leppert, and J. D. Kriesel. 2008. Identification of a herpes simplex labialis susceptibility region on human chromosome 21. J. Infect. Dis. 197:340-346.
35. + T cells by exogenous cell-associated antigens. Immunity 17:211-220.
36. Kaufman, H. E., A. M. Azcuy, E. D. Varnell, G. D. Sloop, H. W. Thompson, and J. M. Hill. 2005. HSV-1 DNA in tears and saliva of normal adults. Investig. Ophthalmol. Vis. Sci. 46:241-247.
37. Koelle, D. M., J. Benedetti, A. Langenberg, and L. Corey. 1992. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann. Intern. Med. 116:433-437.
38. Koelle, D. M., and H. Ghiasi. 2005. Prospects for developing an effective vaccine against ocular herpes simplex virus infection. Curr. Eye Res. 30:929-942.
39. Kronin, V., K. Winkel, G. Suss, A. Kelso, W. Heath, J. Kirberg, H. von Boehmer, and K. Shortman. 1996. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J. Immunol. 157:3819-3827.
40. Kwissa, M., R. R. Amara, H. L. Robinson, B. Moss, S. Alkan, A. Jabbar, F. Villinger, and B. Pulendran. 2007. Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus. J. Exp. Med. 204:2733-2746.
41. Liesegang, T. J. 1999. Classification of herpes simplex virus keratitis and anterior uveitis. Cornea 18:127-143.
42. Liesegang, T. J. 2001. Herpes simplex virus epidemiology and ocular importance. Cornea 20:1-13.
43. McLellan, A. D., M. Kapp, A. Eggert, C. Linden, U. Bommhardt, E. B. Brocker, U. Kammerer, and E. Kampgen. 2002. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. Blood 99:2084-2093.
44. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255-258.
45. + T cells and subsequently express CD8α and CD205 molecules. J. Exp. Med. 195:1233-1245.
46. Moser, M., and K. M. Murphy. 2000. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1:199-205.
47. Mott, K., D. J. Brick, N. van Rooijen, and H. Ghiasi. 2007. Macrophages are important determinants of acute ocular HSV-1 infection in immunized mice. Investig. Ophthalmol. Vis. Sci. 48:5605-5615.
48. Mott, K. R., G. C. Perng, Y. Osorio, K. G. Kousoulas, and H. Ghiasi. 2007. A recombinant herpes simplex virus type 1 expressing two additional copies of gK is more pathogenic than wild-type virus in two different strains of mice. J. Virol. 81:12962-12972.
49. + dendritic cells are involved in enhancing herpes simplex virus type 1 latency. J. Virol. 82:9870-9879.
50. O'Keeffe, M., H. Hochrein, D. Vremec, J. Pooley, R. Evans, S. Woulfe, and K. Shortman. 2002. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood 99:2122-2130.
51. Osorio, Y., J. Cohen, and H. Ghiasi. 2004. Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines. Investig. Ophthalmol. Vis. Sci. 45:506-514.
52. Osorio, Y., and H. Ghiasi. 2005. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge. J. Virol. 79:3297-3308.
53. Perng, G. C., S. M. Slanina, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 2001. The effect of latency-associated transcript on the herpes simplex virus type 1 latency-reactivation phenotype is mouse strain-dependent. J. Gen. Virol. 82:1117-1122.
54. Pozzi, L. A., J. W. Maciaszek, and K. L. Rock. 2005. Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J. Immunol. 175:2071-2081.
55. Pulendran, B., J. L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C. R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96:1036-1041.
56. Pulendran, B., H. Tang, and T. L. Denning. 2007. Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr. Opin. Immunol. 12:12.
57. Ramirez, M. C., and L. J. Sigal. 2002. Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J. Immunol. 169:6733-6742.
58. Rock, D. L., A. B. Nesburn, H. Ghiasi, J. Ong, T. L. Lewis, J. R. Lokensgard, and S. L. Wechsler. 1987. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol. 61:3820-3826.
59. Roizman, B., and A. E. Sears. 1987. An inquiry into the mechanisms of herpes simplex virus latency. Annu. Rev. Microbiol. 41:543-571.
60. Ronchetti, A., P. Rovere, G. Iezzi, G. Galati, S. Heltai, M. P. Protti, M. P. Garancini, A. A. Manfredi, C. Rugarli, and M. Bellone. 1999. Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines. J. Immunol. 163:130-136.
61. Sarmiento, M., and E. S. Kleinerman. 1990. Innate resistance to herpes simplex virus infection. Human lymphocyte and monocyte inhibition of viral replication. J. Immunol. 144:1942-1953.
62. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-161.
63. Stanberry, L. R. 1986. Herpesvirus latency and recurrence. Prog. Med. Virol. 33:61-77.
64. Steiner, I. 1996. Human herpes viruses latent infection in the nervous system. Immunol. Rev. 152:157-173.
65. Steinman, R. M., and Z. A. Cohn. 1973. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137:1142-1162.
66. Steinman, R. M., M. D. Witmer, M. C. Nussenzweig, L. L. Chen, S. Schlesinger, and Z. A. Cohn. 1980. Dendritic cells of the mouse: identification and characterization. J. Investig. Dermatol. 75:14-16.
67. Stevens, J. G. 1989. Human herpesviruses: a consideration of the latent state. Microbiol. Rev. 53:318-332.
68. Teute, H., R. Braun, H. Kirchner, H. Becker, and K. Munk. 1983. Replication of herpes simplex virus in human T lymphocytes. Intervirology 20:32-41.
69. van den Broeke, L. T., E. Daschbach, E. K. Thomas, G. Andringa, and J. A. Berzofsky. 2003. Dendritic cell-induced activation of adaptive and innate antitumor immunity. J. Immunol. 171:5842-5852.
70. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164:2978-2986.
71. Wechsler, S. L., A. B. Nesburn, R. Watson, S. M. Slanina, and H. Ghiasi. 1988. Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames. J. Virol. 62:4051-4058.
72. Wilhelmus, K. R., C. R. Dawson, B. A. Barron, P. Bacchetti, L. Gee, D. B. Jones, H. E. Kaufman, J. Sugar, R. A. Hyndiuk, P. R. Laibson, R. D. Stulting, P. A. Asbell, et al. 1996. Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Br. J. Ophthalmol. 80:969-972.
73. Wu, S. J., G. Grouard-Vogel, W. Sun, J. R. Mascola, E. Brachtel, R. Putvatana, M. K. Louder, L. Filgueira, M. A. Marovich, H. K. Wong, A. Blauvelt, G. S. Murphy, M. L. Robb, B. L. Innes, D. L. Birx, C. G. Hayes, and S. S. Frankel. 2000. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6:816-820.
74. Young, J. W., and R. M. Steinman. 1990. Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells. J. Exp. Med. 171:1315-1332.
75. + T cells. J. Immunol. 175:6428-6435.